window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-P3V9EEXXWH');
CEO Corner2021-02-22T15:55:45+00:00

See how our technology creates Endless Possibilities

CEO Corner

Our Twitter Feed

Nanoplasmid™ could be used to improve 50% of all vectors used in gene therapy trials, including AAV, Lentivirus, Retrovirus and Plasmid DNA.

#genetherapy #vectors

HyperGRO™ fermentation is NTCs high-efficiency process for growing plasmids. The HyperGRO™ media and high cell density fed-batch fermentation process is capable of producing very high yields (> 2 gram/L) of high-quality plasmid DNA in Escherichia coli.

Increased transgene expression and tunable innate immunity activation for gene therapy or vaccination applications – Nanoplasmid™ makes it possible.

This translates to much lower observed toxicity and vector inactivation during cell transfection.

https://lnkd.in/e8gGEMM

The safety concern with marker gene transfer can be eliminated by retrofit of the vector backbone encoded bacterial selection marker to an antibiotic free, non-protein-based selection gene.
We developed an optimized antisense RNA based antibiotic-free selection vector backbone.

The Nanoplasmid™ can be used for multiple applications providing endless possibilities.
To find out more information visit https://natx.com/nanoplasmid/

Load More...
Go to Top